| Completed | Azelastine Allergen Chamber - Onset of Action Study Seasonal Allergic Rhinitis | Phase 2 | 2023-10-30 |
| Completed | Real-world Evidence Study on Cystistat Interstitial Cystitis and Bladder Pain Syndrome | — | 2022-10-21 |
| Completed | Dymista Allergen Chamber - Onset of Action Study Seasonal Allergic Rhinitis | Phase 4 | 2020-12-14 |
| Completed | DYmista NAsal Spray in CHInese Patients Allergic Rhinitis | Phase 3 | 2018-06-29 |
| Completed | MP-AzeFlu Allergen Chamber - Onset of Action Study Seasonal Allergic Rhinitis | Phase 4 | 2017-01-07 |
| Completed | Long-term Effects of Imiquimod and Diclofenac in Actinic Keratoses (LEIDA 2) Actinic Keratosis | Phase 4 | 2011-10-01 |
| Terminated | Tepilta® Versus Oxetacaine, Antacids and Placebo Radiation-induced Oesophagitis | Phase 3 | 2011-04-01 |
| Completed | Relative Potency of Formoterol Novolizer® 12 µg Compared to Formoterol Aerolizer® 12 µg Asthma | Phase 2 | 2010-12-01 |
| Completed | Single Dose Pharmacokinetics of Intranasal Fluticasone Delivered by a Fixed Combination With Azelastine (MP29 Allergic Rhinitis | Phase 1 | 2010-08-01 |
| Completed | Single Dose Pharmacokinetics of Intranasal Azelastine Delivered by a Fixed Combination With Fluticasone in Com Allergic Rhinitis | Phase 1 | 2010-08-01 |
| Completed | Long-term Effects of Imiquimod and Diclofenac in Actinic Keratoses Actinic Keratosis | Phase 4 | 2008-12-01 |
| Completed | To Assess the Protective Effect of the Fixed Drug Combination of Disodium Cromoglycate Plus Reproterol Asthma, Exercise-Induced | Phase 2 | 2007-11-01 |
| Completed | Evaluation of Two Different Non-invasive Techniques to Monitor the Clearance of Actinic Keratosis Lesions Actinic Keratosis | Phase 3 | 2006-02-01 |
| Completed | Study of Imiquimod Cream Prior to Ablative Therapy in External Ano-Genital Warts Genital Warts | Phase 4 | 2005-06-01 |
| Completed | A Study to Follow up Recurrence Rates of Actinic Keratoses One Year After Completion of Study 1487-IMIQ Actinic Keratoses | — | 2005-04-01 |
| Completed | Assessment of Efficacy and Safety of Thioctic Acid in the Oral Treatment of Symptomatic Diabetic Neuropathy (S Diabetic Polyneuropathy | Phase 3 | 2005-02-01 |
| Completed | 5-Year Safety Study of Pimecrolimus Cream 1% in Infants 3 - 12 Months of Age With Mild to Moderate Atopic Derm Atopic Dermatitis | Phase 3 | 2004-04-01 |
| Completed | To Evaluate the Impact of Oral Flecainide on Quality of Life in Patients With Paroxysmal Atrial Fibrillation Atrial Fibrillation | Phase 4 | 2003-09-01 |
| Completed | Aldara for the Treatment of Large and/or Multiple sBCC Carcinoma, Basal Cell | Phase 3 | 2003-05-01 |
| Completed | A Study to Evaluate the Effectiveness and Safety of Multiple Applications of Imiquimod 5% Cream for the Treatm Actinic Keratosis | Phase 2 | 2002-11-01 |
| Completed | Imiquimod 5% Cream in the Treatment of External Genital or Perianal Warts in HIV+ Patients Warts | Phase 4 | 2002-08-01 |
| Completed | A Study to Evaluate Effectiveness of Imiquimod 5% Cream in Superficial Basal Cell Carcinoma Basal Cell Carcinoma | Phase 3 | 2001-02-01 |
| Completed | Assessment of Efficacy and Safety of Thioctic Acid in the Oral Treatment of Diabetic Polyneuropathy (Stage 1 o Diabetic Polyneuropathy | Phase 3 | 1998-05-01 |
| Terminated | Comparative Study of Flecainide CR and Placebo in the Early Treatment of Atrial Fibrillation. Atrial Fibrillation | Phase 4 | — |